Introduction: Bladder cancer (BC), the most prevalent type of cancer in the urinary system globally, presents a substantial health challenge worldwide. Although the global burden of disease (GBD) study provides valuable insights, thorough analyses of BC are still scarce. This study utilizes the latest GBD dataset to examine the impact of BC, combining current statistics with projections for 2036. Methods: We analyzed data from the 2021 GBD Study, concentrating on BC-related metrics: prevalence, incidence, deaths, and disability-adjusted life years (DALYs) across 204 countries and territories, categorized into 21 GBD regions and 5 sociodemographic index (SDI) regions based on the SDI. The data analysis encompassed calculations of relative change, annual percentage change (APC), and estimated APC (EAPC). This research utilized the Spearman algorithm to assess the correlation between disease burden and SDI, conducted age-period-cohort analysis, and performed decomposition analysis. An autoregressive integrated moving average model was employed to forecast trends for the subsequent 15 years. Results: From 1990 to 2021, the global prevalence of BC cases surged by 127.65%, exceeding 3.02 million, even though age-standardized rates declined. A comparable trend was observed in mortality and DALYs, with absolute numbers increasing while age-standardized rates declined. Gender data from 1990 to 2021 revealed a consistent male predominance in BC prevalence, despite decreasing rates for both sexes. A notable association exists between the disease burden of SDI and BC, and the age-period-cohort model has revealed additional insights. Decomposition analysis suggests that population growth is the primary factor influencing the burden of BC disease, yet predictive analysis projects a decrease in age-standardized disease burden over the next 15 years. Conclusions: Our analysis reveals a complex interplay between sociodemographic factors and BC trends, underscoring the need for targeted healthcare interventions. Despite progress, vigilance and continued research are crucial for effective BC management globally.

1.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2020
.
CA Cancer J Clin
.
2020
;
70
(
1
):
7
30
.
2.
Liu
X
,
Liu
S
,
Piao
C
,
Zhang
Z
,
Zhang
X
,
Jiang
Y
, et al
.
Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer
.
Cancer Sci
.
2021
;
112
(
12
):
4909
19
.
3.
Kamat
AM
,
Hahn
NM
,
Efstathiou
JA
,
Lerner
SP
,
Malmström
P-U
,
Choi
W
, et al
.
Bladder cancer
.
Lancet
.
2016
;
388
(
10061
):
2796
810
.
4.
Lv
S
,
Shi
Z
,
Wang
X
,
Zheng
P
,
Li
H
,
Han
Q
, et al
.
Ribosome binding protein 1 correlates with prognosis and cell proliferation in bladder cancer
.
Onco Targets Ther
.
2020
;
13
:
6699
707
.
5.
GBD 2019 Diseases and Injuries Collaborators
.
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019
.
Lancet
.
2020
;
396
(
10258
):
1204
22
.
6.
Wafa
HA
,
Wolfe
CDA
,
Emmett
E
,
Roth
GA
,
Johnson
CO
,
Wang
Y
.
Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years
.
Stroke
.
2020
;
51
(
8
):
2418
27
.
7.
Li
X
,
Cao
X
,
Guo
M
,
Xie
M
,
Liu
X
.
Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the global burden of disease study 2017
.
BMJ
.
2020
;
368
:
m234
.
8.
Zhang
L-Y
,
Wang
P
,
Wang
Y-B
,
He
Z-Q
.
Global, regional, and national burden of bladder cancer, 1990-2019: an age-period-cohort analysis based on the global burden of disease 2019 study
.
Public Health
.
2024
;
236
:
193
203
.
9.
Safiri
S
,
Kolahi
A-A
,
Naghavi
M
;
Global Burden of Disease Bladder Cancer Collaborators
.
Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019
.
BMJ Glob Health
.
2021
;
6
(
11
):
e004128
.
10.
Wu
B
,
Li
Y
,
Shi
B
,
Zhang
X
,
Lai
Y
,
Cui
F
, et al
.
Temporal trends of breast cancer burden in the Western Pacific region from 1990 to 2044: implications from the global burden of disease study 2019
.
J Adv Res
.
2024
;
59
:
189
99
.
11.
Wang
F
,
Ma
B
,
Ma
Q
,
Liu
X
.
Global, regional, and national burden of inguinal, femoral, and abdominal hernias: a systematic analysis of prevalence, incidence, deaths, and DALYs with projections to 2030
.
Int J Surg
.
2024
;
110
(
4
):
1951
67
.
12.
GBD 2021 Nervous System Disorders Collaborators
.
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the global burden of disease study 2021
.
Lancet Neurol
.
2024
;
23
(
4
):
344
81
.
13.
Jiang
C-Y
,
Han
K
,
Yang
F
,
Yin
S-Y
,
Zhang
L
,
Liang
B-Y
, et al
.
Global, regional, and national prevalence of hearing loss from 1990 to 2019: a trend and health inequality analyses based on the global burden of disease study 2019
.
Ageing Res Rev
.
2023
;
92
:
102124
.
14.
Zhang
D
,
Liu
S
,
Li
Z
,
Wang
R
.
Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study
.
Ann Med
.
2022
;
54
(
1
):
1372
84
.
15.
Liu
Z
,
Jiang
Y
,
Yuan
H
,
Fang
Q
,
Cai
N
,
Suo
C
, et al
.
The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention
.
J Hepatol
.
2019
;
70
(
4
):
674
83
.
16.
Zhang
Y
,
Liu
J
,
Han
X
,
Jiang
H
,
Zhang
L
,
Hu
J
, et al
.
Long-term trends in the burden of inflammatory bowel disease in China over three decades: a joinpoint regression and age-period-cohort analysis based on GBD 2019
.
Front Public Health
.
2022
;
10
:
994619
.
17.
Kim
HJ
,
Fay
MP
,
Feuer
EJ
,
Midthune
DN
.
Permutation tests for joinpoint regression with applications to cancer rates
.
Stat Med
.
2000
;
19
(
3
):
335
51
.
18.
Du
M
,
Chen
W
,
Liu
K
,
Wang
L
,
Hu
Y
,
Mao
Y
, et al
.
The global burden of leukemia and its attributable factors in 204 countries and territories: findings from the global burden of disease 2019 study and projections to 2030
.
J Oncol
.
2022
;
2022
:
1612702
.
19.
Lu
Y
,
Shang
Z
,
Zhang
W
,
Hu
X
,
Shen
R
,
Zhang
K
, et al
.
Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: a systematic analysis for the global burden of disease 2021 study
.
Ageing Res Rev
.
2025
;
103
:
102598
.
20.
Yang
Y
.
Social inequalities in happiness in the United States, 1972 to 2004: an age-period-cohort analysis
.
Am Sociol Rev
.
2008
;
73
(
2
):
204
26
.
21.
Xie
Y
,
Bowe
B
,
Mokdad
AH
,
Xian
H
,
Yan
Y
,
Li
T
, et al
.
Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
.
Kidney Int
.
2018
;
94
:
567
581
.
22.
Nguyen
HV
,
Naeem
MA
,
Wichitaksorn
N
,
Pears
R
.
A smart system for short-term price prediction using time series models
.
Comput Electr Eng
.
2019
;
76
:
339
52
.
23.
Li
Y
,
Ning
Y
,
Shen
B
,
Shi
Y
,
Song
N
,
Fang
Y
, et al
.
Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the global burden of disease study 2019
.
Clin Kidney J
.
2023
;
16
(
2
):
312
21
.
24.
Zhao
X
,
Wang
Y
,
Liang
C
.
Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis
.
Int Urol Nephrol
.
2022
;
54
(
6
):
1169
85
.
25.
Xiang
Z
,
Ye
Z
,
Ma
J
,
Lin
Y
,
Zhou
Y
.
Temporal trends and projections of bladder cancer burden in China from 1990 to 2030: findings from the global burden of disease study
.
Clin Epidemiol
.
2022
;
14
:
1305
15
.
26.
Neuzillet
Y
,
Geiss
R
,
Caillet
P
,
Paillaud
E
,
Mongiat-Artus
P
.
[Epidemiological, pathological and prognostic characteristics of bladder cancer in elderly patients]
.
Prog Urol
.
2019
;
29
(
14
):
840
8
.
27.
Hu
X
,
Li
G
,
Wu
S
.
Advances in diagnosis and therapy for bladder cancer
.
Cancers
.
2022
;
14
(
13
):
3181
.
28.
Botteri
E
,
Ferrari
P
,
Roswall
N
,
Tjønneland
A
,
Hjartåker
A
,
Huerta
JM
, et al
.
Alcohol consumption and risk of urothelial cell bladder cancer in the European prospective investigation into cancer and nutrition cohort
.
Int J Cancer
.
2017
;
141
(
10
):
1963
70
.
29.
Zhu
Z
,
Wang
X
,
Shen
Z
,
Lu
Y
,
Zhong
S
,
Xu
C
.
Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
.
BMC Cancer
.
2013
;
13
:
310
.
30.
Loomis
D
,
Guyton
KZ
,
Grosse
Y
,
Lauby-Secretan
B
,
El Ghissassi
F
,
Bouvard
V
, et al
.
Carcinogenicity of drinking coffee, mate, and very hot beverages
.
Lancet Oncol
.
2016
;
17
(
7
):
877
8
.
31.
Wu
S
,
Li
F
,
Huang
X
,
Hua
Q
,
Huang
T
,
Liu
Z
, et al
.
The association of tea consumption with bladder cancer risk: a meta-analysis
.
Asia Pac J Clin Nutr
.
2013
;
22
(
1
):
128
37
.
32.
Cumberbatch
MGK
,
Jubber
I
,
Black
PC
,
Esperto
F
,
Figueroa
JD
,
Kamat
AM
, et al
.
Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018
.
Eur Urol
.
2018
;
74
(
6
):
784
95
.
33.
Saint-Jacques
N
,
Parker
L
,
Brown
P
,
Dummer
TJ
.
Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence
.
Environ Health
.
2014
;
13
:
44
.
34.
GBD 2017 US Neurological Disorders Collaborators
;
Feigin
VL
,
Vos
T
,
Alahdab
F
,
Amit
AML
,
Bärnighausen
TW
, et al
.
Burden of neurological disorders across the US from 1990-2017: a global burden of disease study
.
JAMA Neurol
.
2021
;
78
(
2
):
165
76
.
35.
Tropeano
MP
,
Spaggiari
R
,
Ileyassoff
H
,
Mabunda
DJD
,
Anania
CD
,
Costa
F
, et al
.
Traumatic spine injury: which discrepancy between the research output and the actual burden of the disease
.
World Neurosurg
.
2020
;
142
:
e117
25
.
36.
Khadra
MH
,
Pickard
RS
,
Charlton
M
,
Powell
PH
,
Neal
DE
.
A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice
.
J Urol
.
2000
;
163
(
2
):
524
7
.
37.
Luo
C
,
Lei
T
,
Zhao
M
,
Meng
Q
,
Zhang
M
.
CD40 is positively correlated with the expression of nucleophosmin in cisplatin-resistant bladder cancer
.
J Oncol
.
2020
;
2020
:
3676751
.
38.
Cheung
G
,
Sahai
A
,
Billia
M
,
Dasgupta
P
,
Khan
MS
.
Recent advances in the diagnosis and treatment of bladder cancer
.
BMC Med
.
2013
;
11
:
13
.
39.
Bray
F
,
Ferlay
J
,
Soerjomataram
I
,
Siegel
RL
,
Torre
LA
,
Jemal
A
.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
.
2018
;
68
(
6
):
394
424
.
You do not currently have access to this content.